The Record
Reporting, posts and video from the researchers, physicians and organizations leading this fight, in one place. Every item links to the original. Items marked AJF Original are our own reporting.
3 stories from FDA
The September announcement framed leucovorin as an autism treatment. The March follow-through narrowed it sharply, a reminder that a label authorization and a broad autism indication are not the same thing.
Reform advocates point to 1999 as the moment the government itself conceded there was a mercury-exposure problem worth acting on, the historical foundation of the modern causation argument.
This is the moment the vaccine- and toxin-causation debate moved into official federal policy. A sitting president and HHS secretary, standing together, directed the FDA to act, the first time the government has formally tied a common exposure to autism and authorized a treatment.